|
1
|
Huang J, Shi T, Ma T, Zhang Y, Ma X, Lu Y,
Song Q, Liu W, Ma D and Qiu X: CCDC134, a novel secretory protein,
inhibits activation of ERK and JNK, but not p38 MAPK. Cell Mol Life
Sci. 65:338–349. 2008. View Article : Google Scholar
|
|
2
|
Zhong J, Zhao M, Luo Q, Ma Y, Liu J, Wang
J, Yang M, Yuan X, Sang J and Huang C: CCDC134 is down-regulated in
gastric cancer and its silencing promotes cell migration and
invasion of GES-1 and AGS cells via the MAPK pathway. Mol Cell
Biochem. 372:1–8. 2013. View Article : Google Scholar
|
|
3
|
Huang J, Xiao L, Gong X, Shao W, Yin Y,
Liao Q, Meng Y, Zhang Y, Ma D and Qiu X: Cytokine-like molecule
CCDC134 contributes to CD8+ T-cell effector functions in
cancer immuno-therapy. Cancer Res. 74:5734–5745. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Huang J, Zhang L, Liu W, Liao Q, Shi T,
Xiao L, Hu F and Qiu X: CCDC134 interacts with hADA2a and functions
as a regulator of hADA2a in acetyltransferase activity, DNA
damage-induced apoptosis and cell cycle arrest. Histochem Cell
Biol. 138:41–55. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Schiltz RL, Mizzen CA, Vassilev A, Cook
RG, Allis CD and Nakatani Y: Overlapping but distinct patterns of
histone acetylation by the human coactivators p300 and PCAF within
nucleosomal substrates. J Biol Chem. 274:1189–1192. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Garlanda C, Dinarello CA and Mantovani A:
The interleukin-1 family: Back to the future. Immunity.
39:1003–1018. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yang H, Wang H, Chavan SS and Andersson U:
High mobility group box protein 1 (HMGB1): The prototypical
endogenous danger molecule. Mol Med. 21(Suppl 1): S6–S12.
2015.PubMed/NCBI
|
|
8
|
Li G, Xu C, Lin X, Qu L, Xia D, Hongdu B,
Xia Y, Wang X, Lou Y, He Q, et al: Deletion of Pdcd5 in mice led to
the deficiency of placenta development and embryonic lethality.
Cell Death Dis. 8:e28112017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−ΔΔC(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar
|
|
10
|
Farley FW, Soriano P, Steffen LS and
Dymecki SM: Widespread recombinase expression using FLPeR (flipper)
mice. Genesis. 28:106–110. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Rodríguez CI, Buchholz F, Galloway J,
Sequerra R, Kasper J, Ayala R, Stewart AF and Dymecki SM:
High-efficiency deleter mice show that FLPe is an alternative to
Cre-loxP. Nat Genet. 25:139–140. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lewandoski M, Meyers EN and Martin GR:
Analysis of Fgf8 gene function in vertebrate development. Cold
Spring Harb Symp Quant Biol. 62:159–168. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
de Vries WN, Binns LT, Fancher KS, Dean J,
Moore R, Kemler R and Knowles BB: Expression of Cre recombinase in
mouse oocytes: A means to study maternal effect genes. Genesis.
26:110–112. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Renaud SJ, Karim Rumi MA and Soares MJ:
Review: Genetic manipulation of the rodent placenta. Placenta.
32(Suppl 2): S130–S135. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Dzierzak E, Medvinsky A and de Bruijn M:
Qualitative and quantitative aspects of haematopoietic cell
development in the mammalian embryo. Immunol Today. 19:228–236.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Koulnis M, Pop R, Porpiglia E, Shearstone
JR, Hidalgo D and Socolovsky M: Identification and analysis of
mouse erythroid progenitors using the CD71/TER119 flow-cytometric
assay. J Vis Exp. 54:e28092011.
|
|
17
|
Breier G, Clauss M and Risau W: Coordinate
expression of vascular endothelial growth factor receptor-1 (flt-1)
and its ligand suggests a paracrine regulation of murine vascular
development. Dev Dyn. 204:228–239. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Slack JM: Essential Developmental Biology.
3rd edition. Wiley-Blackwell; Oxford: 2012
|
|
19
|
Savolainen SM, Foley JF and Elmore SA:
Histology atlas of the developing mouse heart with emphasis on
E11.5 to E18.5. Toxicol Pathol. 37:395–414. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Folkman J: Angiogenesis in cancer,
vascular, rheumatoid and other disease. Nat Med. 1:27–31. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Smith AG: Embryo-derived stem cells: Of
mice and men. Annu Rev Cell Dev Biol. 17:435–462. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Coşkun S, Chao H, Vasavada H, Heydari K,
Gonzales N, Zhou X, de Crombrugghe B and Hirschi KK: Development of
the fetal bone marrow niche and regulation of HSC quiescence and
homing ability by emerging osteolineage cells. Cell Rep. 9:581–590.
2014. View Article : Google Scholar :
|
|
23
|
Golub R and Cumano A: Embryonic
hematopoiesis. Blood Cells Mol Dis. 51:226–231. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Grant PA, Duggan L, Côté J, Roberts SM,
Brownell JE, Candau R, Ohba R, Owen-Hughes T, Allis CD, Winston F,
et al: Yeast Gcn5 functions in two multisubunit complexes to
acetylate nucleosomal histones: Characterization of an Ada complex
and the SAGA (Spt/Ada) complex. Genes Dev. 11:1640–1650. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yamauchi T, Yamauchi J, Kuwata T, Tamura
T, Yamashita T, Bae N, Westphal H, Ozato K and Nakatani Y: Distinct
but overlapping roles of histone acetylase PCAF and of the closely
related PCAF-B/GCN5 in mouse embryogenesis. Proc Natl Acad Sci USA.
97:11303–11306. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Jin Q, Yu LR, Wang L, Zhang Z, Kasper LH,
Lee JE, Wang C, Brindle PK, Dent SY and Ge K: Distinct roles of
GCN5/PCAF-mediated H3K9ac and CBP/p300-mediated H3K18/27ac in
nuclear receptor transactivation. EMBO J. 30:249–262. 2011.
View Article : Google Scholar :
|
|
27
|
Malatesta M, Steinhauer C, Mohammad F,
Pandey DP, Squatrito M and Helin K: Histone acetyltransferase PCAF
is required for Hedgehog-Gli-dependent transcription and cancer
cell proliferation. Cancer Res. 73:6323–6333. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hemberger M, Dean W and Reik W: Epigenetic
dynamics of stem cells and cell lineage commitment: Digging
Waddington's canal. Nat Rev Mol Cell Biol. 10:526–537. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Burton A and Torres-Padilla ME: Chromatin
dynamics in the regulation of cell fate allocation during early
embryogenesis. Nat Rev Mol Cell Biol. 15:723–734. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ziegler-Birling C, Daujat S, Schneider R
and Torres-Padilla ME: Dynamics of histone H3 acetylation in the
nucleosome core during mouse pre-implantation development.
Epigenetics. 11:553–562. 2016. View Article : Google Scholar :
|
|
31
|
Rahimi N and Costello CE: Emerging roles
of post-translational modifications in signal transduction and
angiogenesis. Proteomics. 15:300–309. 2015. View Article : Google Scholar :
|
|
32
|
Zecchin A, Pattarini L, Gutierrez MI, Mano
M, Mai A, Valente S, Myers MP, Pantano S and Giacca M: Reversible
acetylation regulates vascular endothelial growth factor receptor-2
activity. J Mol Cell Biol. 6:116–127. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Bastiaansen AJ, Ewing MM, de Boer HC, van
der Pouw Kraan TC, de Vries MR, Peters EA, Welten SM, Arens R,
Moore SM, Faber JE, et al: Lysine acetyltransferase PCAF is a key
regulator of arteriogenesis. Arterioscler Thromb Vasc Biol.
33:1902–1910. 2013. View Article : Google Scholar : PubMed/NCBI
|
